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Abstract
Background: Pathological angiogenesis represents a critical issue in the progression of many diseases. Down
syndrome is postulated to be a systemic anti-angiogenesis disease model, possibly due to increased expression of
anti-angiogenic regulators on chromosome 21. The aim of our study was to elucidate some features of circulating
endothelial progenitor cells in the context of this syndrome.
Methods: Circulating endothelial progenitors of Down syndrome affected individuals were isolated, in vitro
cultured and analyzed by confocal and transmission electron microscopy. ELISA was performed to measure SDF-1a
plasma levels in Down syndrome and euploid individuals. Moreover, qRT-PCR was used to quantify expression
levels of CXCL12 gene and of its receptor in progenitor cells. The functional impairment of Down progenitors was
evaluated through their susceptibility to hydroperoxide-induced oxidative stress with BODIPY assay and the major
vulnerability to the infection with human pathogens. The differential expression of crucial genes in Down
progenitor cells was evaluated by microarray analysis.
Results: We detected a marked decrease of progenitors’ number in young Down individuals compared to euploid,
cell size increase and some major detrimental morphological changes. Moreover, Down syndrome patients also
exhibited decreased SDF-1a plasma levels and their progenitors had a reduced expression of SDF-1a encoding
gene and of its membrane receptor. We further demonstrated that their progenitor cells are more susceptible to
hydroperoxide-induced oxidative stress and infection with Bartonella henselae. Further, we observed that most of
the differentially expressed genes belong to angiogenesis, immune response and inflammation pathways, and that
infected progenitors with trisomy 21 have a more pronounced perturbation of immune response genes than
infected euploid cells.
Conclusions: Our data provide evidences for a reduced number and altered morphology of endothelial progenitor
cells in Down syndrome, also showing the higher susceptibility to oxidative stress and to pathogen infection
compared to euploid cells, thereby confirming the angiogenesis and immune response deficit observed in Down
syndrome individuals.
Background
Down syndrome (DS) is a complex disorder caused by
trisomy of the entire or a critical portion of chromo-
some 21 (HSA21); it represents the most frequent
genetic cause of mental retardation, with a frequency of
about 1/1000 new-borns, and is associated with a huge
number of congenital heart defects [1]. DS individuals
have also an increased risk of early-onset Alzheimer dis-
ease [1]. Immunological and autoimmune disturbances,
with high rates of infections and malignancies, are
recurrent phenomena in DS pathogenesis [2], and infec-
tions still represent major cause of death in DS [3,4].
Despite the increased risk of leukaemia, DS patients
have a low incidence to develop solid tumors [5,6], and
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a reduced incidence of diabetic retinopathy, suggesting,
at least in part, a common angiogenesis’ suppression
[5,7]. Impaired endothelial function at a young age, pos-
sibly due to increased oxidative stress and yet unknown
mechanisms, is a common DS feature [8].
DS phenotype results from a dosage imbalance of
HSA21 genes, although expression analyses have
reported conflicting results [9,10]. The over-expression
of chromosome 21 genes greatly varies across the triso-
mic tissues [11,12], and analyzing specific cell type/tis-
sue, in easy-accessible and non-invasive manner, may be
more productive [13,14].
Growing interest is emerging on circulating endothe-
lial progenitor cells (EPCs) and their pivotal role in the
maintenance of endothelium integrity, repair after injury
and postnatal neovascularization [15-17]. Many studies
are providing encouraging insights into the use of EPCs
in the clinical setting [18,19]. Indeed, accumulating evi-
dences indicate a reduced availability, and/or impaired
EPC function, in cardiovascular and metabolic diseases
[17,20,21]. EPCs number was recently shown to be
impaired in DS fetuses and children [22,23] and CD34+
haematopoietic progenitors exhibited a marked growth
decrease in Ts65Dn - a DS mouse model - accounting,
at least in part, for DS vascular anomalies and defective
immune response to pathogens [24].
Bacterial toxins may trigger pathogenic events through
the over-production of cytokines and chemokines, lead-
ing to the alteration of endothelial function and capillary
leakage [25]. Particularly, we recently demonstrated [26]
that Bartonella henselae, a gram-negative intracellular
bacteria responsible of vasoproliferative disorders in
immunocompromised individuals [27,28], adheres to
and invades EPCs.
The present study was designed to pursue the molecular
mechanisms contributing to immune, vascular and haema-
topoietic defective DS phenotypes, by investigating the
number and functions of DS EPCs compared to euploid
cells, also focusing on bioinformatics analysis of differen-
tially expressed genes. Moreover, by using the previously
described B. henselae model, we investigated the suscept-
ibility of DS progenitors to this pathogen infection, also
performing a detailed analysis of deregulated genes after
Bartonella infection, with particular attention to angiogen-
esis and immune response pathways.
Methods
Subjects
DS and euploid donors were recruited at the Institute of
General Pathology, Section of Clinical Pathology, Faculty
of Medicine, University of Milan, and at the Second
University of Naples, and an approval statement was
obtained by the ethics’ review boards of both Institu-
tions. Informed consent was obtained from all persons
involved in all clinical investigation of this study accord-
ing to the principles expressed in the Declaration of
Helsinki.
All subjects recruited for EPC isolation were free of
infection, and no individual was taking any medication
known to affect immune system/response. DS and
euploid individuals were 65% males and 35% females as
gender and 28 ± 9 as mean age. The experiments,
where not specified, were performed on at least six DS
and age-matched euploid individuals.
Plasma samples were obtained from 50 DS individuals
and 30 age matched euploids subdivided into three age
subgroups (young 0-20 y.o.; adult 21-40 y.o.; old 41-60
y.o.) as described elsewhere [29].
EPC Isolation
EPCs were isolated from non-institutionalized indivi-
duals with DS and age-matched euploid donors.
EPCs were isolated as previously described [30].
Briefly, PBMCs were isolated by density gradient centri-
fugation of peripheral blood samples on Histopaque-
1077 (Sigma). Cells were washed twice with PBS and
counted. PBMCs were plated on culture dishes pre-
coated with gelatin and fibronectin and maintained in
endothelial basal medium-2 (EBM2; Cell Systems). Cells
were cultured at 37°C with 5% CO2 in a humidified
atmosphere. After four days, non-adherent cells were
removed and adherent cells were used for further
analyses.
Bacterial strains and growth conditions
The B. henselae strain ATCC 49882 (LGC Promochem)
was grown on Columbia agar supplemented with 5% defi-
brinated sheep blood (Oxoid) in a humidified atmosphere
at 37°C and 5% CO2. For production of bacterial stock
suspensions, bacteria were harvested after 7 days of cul-
ture until they reached the mid-exponential phase of
growth (109 bacteria/ml), resuspended in Tryptone Soya
Broth USP (Oxoid) containing 10% glycerol, and stored
at -80°C. The number of viable bacteria in the frozen
stocks was determined as previously described [26].
B. henselae infection
For infection, Bartonella stock solutions were thawed,
washed and suspended in antibiotic-free cell culture
medium, and sedimented onto cultured EPCs at differ-
ent multiplicity of infection (MOI) of 50, 100, 250, 500
and 1000 [26]. The MOI for infections was confirmed
by plating serial dilutions of the infection inoculum.
Assays were performed three times in triplicate.
Confocal immunofluorescence microscopy
EPCs were dual stained with Dil-Ac-LDL and lectin
from Ulex europaeus and counted both by fluorescence
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microscopy and flow cytometry as previously described
[26,30]. Images were obtained by Zeiss LSM 510 with
plan-apochromat X 63 (NA 1.4) oil immersion objective.
EPCs images were used to measure cell size with ImageJ
(http://rsb.info.nih.gov/ij/).
SDF-1a plasma levels
Commercially available SDF-1a ELISA kit (Quantikine,
R&D Systems) was used to determine plasma SDF-1a
levels. Tests were carried out at RT on freshly thawed
plasma samples of 50 DS individuals and 30 age
matched euploids subdivided into three age subgroups
(young 0-20 y.o.; adult 21-40 y.o.; old 41-60 y.o.) [29].
Concentration was determined by comparison with a
standard curve, following manufacturer’s instruction.
Transmission electron microscopy
After a short incubation with Trypsin/EDTA, DS and
euploid EPCs, both infected and uninfected with B. hen-
selae, were harvested, centrifuged and washed in PBS.
After centrifugation at a speed of 400 g for 7 min, cells
were fixed in 4% glutaraldehyde as described [31]. Post-
fixation, dehydratation of specimen, semithin (2 μm)
and ultrathin (80 nm) sections were performed as pre-
viously described [26]. Semithin sections were analysed
with a light microscope (Polivar Reichert-Jung). Ultra-
thin sections were examined with Leo 912 AB transmis-
sion electron microscope operating at 80 kV.
C11-BODIPY581/591 fluorescence
Oxidation-sensitive fluorescent probe, C11-BODIPY581/
591 (C11-BO, Invitrogen), was loaded (2 μM final con-
centration) into the cells 30 min. before oxidative treat-
ment. The samples were aliquoted in triplicate wells of a
24-well microplate, and fluorescence was determined
with confocal laser microscopy at different times (0, 1,
and 6 hours) from oxidant treatment. Between times,
plates were maintained at 37°C in 5% CO2. To determine
red fluorescence each microplate was excited at 543 nm
(emission at 590 nm); for green fluorescence, microplates
were excited at 488 nm (emission at 526 nm). Blank wells
were also evaluated as well as C11-BO alone.
Microarray analysis and quantitative RT-PCR
Total RNA (10 μg) was isolated as previously described
[32] [Additional file 1: Supplementary Methods]. A pool
of three samples (a total 15 μg of cRNA) was used for
each hybridization - 2 pools of three infected and three
uninfected euploid and DS - on the Affymetrix U133 2.0
probe array cartridge as described elsewhere [26].
Microarray data were submitted to Array Express
(http://www.ebi.ac.uk/arrayexpress; provisional accession
number E-MTAB-312). Results were validated by qRT-
PCR and semi-qRT-PCR, performed as described [32],
using primer pairs listed in [Additional file 2: Supple-
mental Table S1].
In silico significant pathway identification
Analysis of over-represented genes was performed using
the Database for Annotation, Visualization, and Inte-
grated Discovery (DAVID) [33,34] and the PANTHER
(Protein ANalysis THrough Evolutionary Relationships)
Classification System [35 [Additional file 1: Supplemen-
tary Methods].
Statistical analysis
EPCs number, cell size differences, SDF-1a plasma levels,
fluorescence intensity of C11-BO and qRT-PCRs data were
reported as mean values, and results analysed by paired
Student t test. P value < 0.05 was considered statistically
significant [Additional file 1: Supplementary Methods].
Results
EPC number and phenotype
We established that the number of EPCs isolated from
peripheral blood of young and adult (mean age 28 ± 9)
DS was significantly lower than age-matched euploid
individuals (P < 0.0001 vs euploid EPCs; see Figure 1A).
Phase contrast fluorescent microscopy [Additional file 3:
Supplemental Figure S1A] and FACS analysis (data not
shown) were used to identify double-positive cells for
Dil-Ac-LDL and lectin [26,30]. By confocal microscopy
and TEM we also observed early signs of cytoplasmatic
disruption in DS progenitors, and cell size increase com-
pared to euploid. In particular, by using ImageJ, we
measured the cell size of DS EPCs, showing a significant
increase compared to euploid cells (Figures 1B and
Additional file 3: Supplemental Figure S1B]). We also
measured cell cycle progression of DS progenitors vs
euploid cells and we did not find any significant differ-
ence [Additional file 3: Supplemental Figure S1C].
Moreover, the ultrastructural examination revealed an
increased number of phagolysosomes and vacuolization
of DS progenitors compared to euploid cells (Figure 1C).
SDF-1a plasma levels
EPC number is known to correlate to chemokines’ plasma
levels, such as SDF-1a (stromal derived factor-1a). Thus,
we first measured by ELISA its plasma levels in peripheral
blood of 30 euploid and 50 DS individuals, collected in
three age subgroups [29]. Then, comparing mean SDF-1a
values we found a significant decrease of SDF-1a plasma
levels in young and adults DS compared to age-matched
euploid individuals (P = 0.02) (Figure 1D).
Moreover, we measured by quantitative RT-PCR the
expression of SDF-1a encoding gene, CXCL12, and of
its membrane receptor CXCR4. A significant decrease in
the expression of CXCL12 (5-fold; P < 0.05) and CXCR4
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(2-fold; P < 0.05) was observed in DS endothelial pro-
genitors compared to euploid cells (Figure 1E).
B. henselae infection of endothelial progenitors
EPCs isolated from young euploid and DS individuals
were infected after 3 days of culture with B. henselae at
different MOI as described elsewhere [26] (Figure 2A).
TEM examination confirmed that B. henselae is interna-
lized by endothelial cells as bacterial aggregates within
invasomes or as single bacteria by protrusions of the
cells. Interestingly, the EPC number was dramatically
impaired in both DS and euploid after bacteria internali-
zation [Additional file 3: Supplemental Figure S1D]. In
contrast, by confocal microscopy at high magnifications
(x630), a more detrimental effect was observed in
infected DS progenitors, showing some morphological
major differences compared to euploid EPCs when the
same non-lethal MOI of Bartonella was used (Figure
2A). Ultrastructural analysis revealed that infected DS
progenitors have increased intracellular accumulation of
bacteria, forming invasomes, compared to euploid cells
infected at the same MOI of 100 (Figure 2B). Cytoplas-
mic protrusions of cell membranes were also observed
in both samples following adherence of the bacteria to
the host cells. Moreover, after infection at higher MOI
(250), DS progenitors showed larger invasomes, also dis-
playing, in some cases, invasome and cell membrane
rupture with subsequent bacteria outflow (Figure 2B). In
contrast, infected euploid cells showed significant lower
number of invasomes. The number of infected DS cells
was estimated to be significantly higher compared to
euploid cells at both MOI used (Figure 2C). We did not
use infection at MOI ≥500 of B. henselae since they
were not compatible with DS progenitors’ survival.
Oxidative stress in DS progenitors
To determine oxidant activities in living cells, mem-
brane lipid peroxidation (LP) of isolated EPCs was mea-
sured by using C11-BO, a fatty acid analogue. We
cultured both DS and euploid EPCs in the presence of a
Figure 1 EPC number, mobilization and morphology in DS. A) EPCs number in euploids and DS determided as Dil-Ac-LDL/Lectin double
positive cells (*P < .0001). B) EPC size measured by confocal microscopy and ImageJ (*P < .0001). C) Morphological characterization by TEM of
EPCs isolated from euploids and DS. Scale bar: 5 ìm. D) SDF-1a plasma levels in DS and euploids (*P < .0001). E) Relative expression levels of
CXCL12 and CXCR4 genes in euploids and DS measured by qRT-PCR (*P < 0.05).
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fixed concentration of hydroperoxide (200 nM) [36],
and performed a time-course (0, 1 and 6 hours) experi-
ment measuring the fluorescence emission by confocal
microscopy. Particularly, in 6-hours treated DS samples,
we observed a significant shift (Figure 3A upper panel)
in the fluorescence emission from red towards green
(590 nm to 520 nm) compared to untreated DS EPCs
(P < 0.01). This shift was not observed in euploid
hydroperoxide-treated EPCs vs untreated, as already
described [36].
To evaluate the protective effects of B. henselae,
known to induce - albeit at low MOI (50) - long-term
endothelial cell survival and proliferation [37,38], the
same experiment was performed on DS and euploid
progenitors infected with a low MOI (about 50) of Bar-
tonella. No differences in LP were observed in both DS
and euploid infected cells compared to uninfected, in
the absence of hydroperoxide treatment (data not
shown). More interestingly, a significant decrease in LP
was observed in Bartonella-infected DS progenitors vs
uninfected (p < 0.01) (Figure 3A lower panel). This find-
ing is in accordance to the previously reported beneficial
effect of infection at low MOI of B. henselae [37,38].
Moreover, it is known that a constitutive increase in
S100B, due to HSA21 trisomy, is likely to induce ROS
generation, leading to increased oxidative stress in DS
[39], and the over-expression of SOD1 gene has been
suggested to be responsible of oxidative damage to neu-
rons [40]. Thus, we measured the expression levels of
both S100B and SOD1 genes in DS and euploid isolated
EPCs, showing their significant over-expression in DS
derived cells (Figure 3B).
Chromosome 21 expression profile
We chose a user fold-change of 2 and a P-value cut-off
of 0.005 for selecting a list of differentially expressed
genes, and we first focused on the HSA21 genes accord-
ing to GenBank annotation. Thus, to evaluate the
impact of an extra copy of chromosome 21 on DS pro-
genitors we performed a detailed analysis of HSA21
genes in DS vs eupolid EPCs. We observed that only
109 out of a total of 386 genes annotated on HSA21
(NCBI RefSeq 36.3), were detected in this microarray
analysis. Furthermore, 52 (about 14% of total HSA21
annotated genes) showed an evidence of differential
expression in DS EPCs compared to euploid cells. In
Figure 2 B. henselae infection. EPCs isolated from DS and euploids were infected at different MOI of Bartonella as indicated. A) Confocal
images of uninfected and infected EPCs at indicated MOI. Cells were stained with Dil-Ac-LDL (red) and lectin (green). B) TEM images of DS and
euploid EPCs infected at the MOI of 100 and 250. Invasomes are highlighted by arrows. Scale bars are 5 ìm, 2 ìm, 5 ìm and 5 ìm, respectively. C)
Bar graph representation of DS and euploid infected cells at different MOI.
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particular, 37 genes were up- and 15 down-regulated
(72% up- and 28% down-regulated, respectively) [Addi-
tional file 4: Supplemental Table S2].
Database searches based on GO classification, revealed
that differentially expressed genes were mostly associated
to immune response (GO:0006955) and transcription reg-
ulation (GO:0045449) (Figure 4A). Particularly, crucial
genes involved in the immune response, such as interferon
receptors (IFNAR1 and IFNAR2), and oxidative stress,
such as SOD1, S100B and APP - recently implicated in DS
neurotoxicity from elevated expression of free radicals [39]
- were highly up-regulated in DS vs euploid EPCs (Figure
3B; Additional file 4: Supplemental Table S2).
Although we observed relatively small up-regulation of
chromosome 21 genes, significant changes in gene
expression were not limited to HSA21 genes. Indeed, we
observed a global and pronounced deregulation overall
the chromosomes, possibly explained by dosage imbal-
ance of HSA21 genes encoding transcriptional factors or
gene expression modulators (Figure 4A; Additional file
4: Supplemental Table S2).
A less frequently explored gene characteristic for
microarray analysis is the chromosomal location of the
genes, especially when studying diseases caused by gen-
ome alterations. First we demonstrated, by using chi-
squared association tests, that differentially expressed
Figure 3 Oxidative stress of EPCs. A) Bar graph representation of C11-BO oxidation at different times (0, 1 and 6 hours) in DS and euploid
EPCs in presence of hydroperoxide (200 ìM). Upper panel, C11-BO oxidation in hydroperoxide-treated euploid EPCs compared to DS (*P < 0.01).
Lower panel, Bartonella-infected euploid and DS progenitors treated and untreated with hydroperoxide (*P < 0.01). B) SOD1 and S100B gene
expression in euploid and DS EPCs by qRT-PCR. Data are shown as relative expression levels (Euploid EPC expression = 1).
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genes are not uniformly distributed along the chromo-
somes. We observed that in DS EPCs the chromosomes
21 - as expected - and 19 were enriched for differentially
expressed genes compared to the other chromosomes
(a 0.001; P = 6.7E-0.6; Additional file 5: Supplemental
Figure S2). As a proof of the robustness of our findings,
the analysis was repeated with different fold-change and
P cut-offs, reporting similar qualitative findings. More-
over, by using positional gene enrichment (PGE)
approach [41] to map a set of genes to the exact loca-
tion on chromosome [Additional file 6: Supplemental
Figure S3], we observed that chromosome 19 has the
highest percent of deregulated genes [Additional file 3:
Supplemental Figure S1A] and, in particular, that the
enriched p12 band contains most of the genes encoding
for transcription factors of the zinc finger protein
superfamily.
Gene pathways’ perturbation in DS progenitors
By using the same selection parameters, the comparison
of global DS and euploid expression profiles revealed
that, after filtering ("Materials and Methods”), 2913
genes (2489 of them with single probe and 424 with
multiple probes) were differentially expressed, on a total
Figure 4 Differentially expressed genes in DS vs euploid progenitors. A) Schematic representation of chromosome 21 differentially
expressed genes in DS vs euploid progenitors. Genes are categorized according to GO classification or their hypothetical biological function. B)
Bar graph representation of more pronounced deregulated gene pathways in the whole genome of DS vs euploids, after PANTHER analysis.
Vertical bars indicate the number of differentially expressed genes per pathway. C) HeatMap showing the fold-change of cell cycle and cell
cycle-related differentially expressed genes in DS vs euploid progenitors. Gray intensity is proportional to the fold-change; the bar on the right
illustrates the association between fold-changes and grayscale. The genes are ranked from the most up-regulated (white) to the most down-
regulated (black). D) qRT-PCR for crucial genes belonging to the most deregulated gene pathways are shown. Data are indicated as relative
expression levels (Euploid EPCs = 1).
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of 11327 distinct genes considered. By using DAVID
and PANTHER Classification System, differentially
expressed genes were categorized according to their
known or hypothetical biological function, and the
enrichment for specific gene pathways was evaluated.
The analysis revealed that most of the deregulated genes
were involved in “angiogenesis”, “inflammation mediated
by cytokines and chemokines”, “integrins” and “interleu-
kines” signaling pathways (Figure 4B). A particular
enrichment was also observed for cell cycle and cell
cycle-related genes (Figure 4C).
Interestingly, angiogenesis inhibitors encoding genes -
such as CXCL10 and other interferon-stimulated genes -
were up-regulated in DS-derived progenitors, whereas,
on the opposite, pro-angiogenic genes (VEGFA,
CXCL12, EDN1, CASP8) were dramatically down-regu-
lated (Table 1).
Since evidences indicate that chemokines, cytokines
and soluble factors affect the mobilization and recruit-
ment of endothelial progenitors [42,43], we evaluated the
expression of some crucial genes by quantitative RT-PCR
(Figure 1E and 4D). Particularly, we observed a down-
regulation of CXCR4 receptor and of its ligand, encoded
by CXCL12 gene, in DS progenitors compared to euploid
cells (Figure 1E), the over-expression of RCAN1 gene (or
DSCR1) and the down-regulation of CXCR7 receptor
(Figure 4D), which play a key role in endothelial cells
migration and homing. No significant differential expres-
sion was observed for IL8 and DYRK1A genes in DS pro-
genitors compared to euploid (Figure 4D).
B. henseale-induced gene expression variations
A similar approach for gene list selection was used to
investigate the genetic response of DS-EPCs to B. hense-
lae infection at a 100 MOI.
GO term enrichment analysis [38] showed that a con-
siderable number of induced/repressed genes belong to
immune and inflammatory response pathways [Addi-
tional file 7: Supplemental Figure S4], with the majority
of genes annotated within the “Jak/STAT” and
“Cytokine-cytokine receptor interaction” pathways.
Furthermore, we categorized the most prominently
up-regulated genes in DS infected EPCs in two related
functional classes: “Interferons related/induced genes”
and “cytokines and chemokines”, consisting of 19 and
32 genes, respectively. The same approach was then
used for infected euploid cells. Transcriptional levels of
related genes, observed by microarray, are shown in
[Additional file 8: Supplemental Table S3].
We focused our interest toward the cluster of differen-
tially expressed genes of the Jak/STAT pathway (Figure 5).
The analysis revealed that DS infected EPCs have a very
distinct “molecular signature” compared to infected
euploid progenitors, mostly characterized by the up-regu-
lation of interferon-stimulated genes (ISGs). Particularly, a
large subset of differentially expressed crucial genes was
also confirmed by semi-quantitative RT-PCR [Additional
file 7: Supplemental Figure S4]. As a reflection of the
robust induction of ISGs, ‘IFN signaling’ was identified as
the top scored pathway induced in DS progenitors after
infection of B. henselae.
Other deregulated genes - involved in cell cycle regu-
lation and gene expression - were further identified,
many of which are known to be targets of interferon
action as a consequence of the anti-proliferative effects.
Discussion
Alteration of EPC number has been described in a wide
range of conditions, such as cardiovascular, inflamma-
tory, immune, and infectious diseases [21,44]. A
decreased in vitro growth capacity of bone marrow-
derived progenitors in DS mouse model Ts65Dn [24]
and a reduced number of CD34+ in DS fetuses and
children were also reported [22]. More recently, Diller
Table 1 Differential expression of angiogenesis-related genes in DS vs C endothelial progenitors
Gene name Gene symbol RefSeq Fold change Function
Chemokine (C-X-C motif) ligand 10 CXCL10 NM_001565 6.7 I Antiangiogenic chemokine
Interferon stimulated gene 20 ISG20 NM_002201 4.4 I Angiogenesis inhibitor
SAM domain- and HD domain-
containing protein 1
SAMHD1 NM_015474 3.0 I Interferon-g stimulated; angiogenesis inhibitor
Caspase 8 CASP8 NM_001228 3.5 D Adhesion and homing of EPC
Chemokine (C-X-C motif) ligand 12 CXCL12 NM_199168 10.2 D; 5.7 D Mobilization and recruitment of EPCs
Chemokine (C-X-C motif) receptor 4 CXCR4 NM_001008540 3.0 D Endothelial cells migration and homing
Chemokine (C-X-C motif) receptor 7 CXCR7 NM_020311 4.3 D Endothelial cells migration and homing
Endothelin 1 EDN1 NM_001955 13.6 D; 3.5 D Promotes migration and proliferation of endothelial cells
Endothelin receptor type B EDNRB NM_000115 2.8 D Migration, proliferation of endothelial cells
Vascular endothelial growth factor A VEGFA NM_001025367 3.6 D Angioproliferative
Stanniocalcin 1 STC1 NM_003155 56.0 D VEGF-mediated angiogenic response
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et al. (2008) reported an impairment of CD34+/AC133
+/KDR+ cells in a small subset of DS individuals
affected by Eisenmenger syndrome [23]. Despite the use
of different experimental approaches and the limited
number of individuals, the reduced number of circulat-
ing progenitors is an important common finding. These
evidences may possibly account for the differences in
angiogenesis, inflammatory and immune response
reported in DS [14].
Here, we have shown that DS patients exhibit a
marked reduction of ≈ 40% in the number of EPCs, also
displaying a significant increase in cell size and major
detrimental morphological changes (i.e., cell vacuoliza-
tion and high number of active lysosomes). The reduced
number of progenitors could be associated with altera-
tions in the cell cycle; however, we did not find any sig-
nificant difference between the groups [Additional file 3:
Supplemental Figure S1C]. Thus, we investigated other
possible mechanisms responsible for the observed EPCs
impairment, such as mobilization/homing and oxidative
stress susceptibility.
Growing evidences indicate that chemokines and cyto-
kines, such as SDF-1a and its receptor CXCR4, play a
crucial role in the mobilization and homing of EPCs
from bone marrow [45,46], also affecting cell prolifera-
tion [41,42]. Our findings of a significant decrease in
SDF-1a plasma levels in young DS - compared to age-
matched euploids - and a strong decrease of CXCL12
and CXCR4 gene transcription in their EPCs, suggest a
link with the reduced number of circulating progenitors
and the angiogenesis suppression observed in DS.
These results are strengthened by microarray analy-
sis, indicating that DS progenitors have a pronounced
perturbation, at least at transcriptional level, in the
angiogenesis and cell cycle pathways. Indeed, by using
this approach we demonstrated the transcriptional
Figure 5 JAK/STAT pathway in infected EPCs. Graphical representation of interferon signalling pathway comprising many of the differentially
expressed genes in infected DS vs euploid EPCs. JAK/STAT pathway up-, down-regulated and “no-change” genes are shown in black, gray and
white, respectively.
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deregulation of CXCR7, IL8 and RCAN1 genes, crucial
factors involved in endothelial cells’ migration, homing
and angiogenesis [47-49]. Moreover, we found a down-
regulation of CASP8, which has been demonstrated to
have a novel apoptosis-unrelated role in proangiogenic
cells [50], although this gene was found to be asso-
ciated with breast cancer by gene-based association
study, and its down-regulation has also been reported
in breast cancer [51].
We recently demonstrated the relevance of oxidative
stress on the number and function of progenitor cells
[52]. Besides, it is known that oxidative stress is a cru-
cial issue in the pathogenesis of DS, especially due to
the high incidence of Alzheimer-like disease at young
age [53]. It has been also suggested that constitutive
expression of trisomic genes, S100B and SOD1, is likely
to represent a leading cause of ROS generation and
increased oxidation in DS neurons [39,40]. Oxidative
stress relevance in DS fetuses was also highlighted by
microarray analysis of uncultured amniotic fluid [54].
Here, we have assessed, by both experimental evi-
dences and microarray analysis, that DS progenitors are
more susceptible to hydroperoxide-induced LP and sig-
nificantly over-express S100B and SOD1 genes. These
findings strengthen the hypothesis of their involvement
in the susceptibility to oxidation observed in DS
endothelial progenitors.
In our study we have infected DS progenitors with a
human pathogen, B. henselae, responsible of vasoproli-
ferative diseases such as bacillary angiomatosis and
peliosis in immunocompromised patients [27,28], pre-
viously demonstrated to adhere to and invade EPCs
[26]. Particularly, we investigated the effect of infection
on DS progenitors’ number, morphology and oxidative
stress response. After hydroperoxide treatment, we
observed a significant LP decrease in Bartonella-infected
DS progenitors compared to uninfected DS cells. This
finding confirms the beneficial effect of B. henselae
infection at low MOI on mature endothelial cells’ survi-
val [37,38].
In contrast, a reduced cell number in both DS and
euploid groups was observed after Bartonella infection
at higher MOIs; however, detrimental changes were visi-
ble only in DS EPCs, displaying a higher number of
invasomes and infected cells compared to euploid cells.
The molecular basis of such Bartonella-induced detri-
mental effect on endothelial progenitors of DS was
investigated at a transcriptional level by microarray. Sig-
nificant up-regulation of the Jak/STAT pathway was
observed only within infected DS progenitors, whereas,
on the opposite, infected euploid cells displayed a signif-
icant down-regulation. These findings strengthen the
hypothesis that transcriptional analysis of EPCs is clearly
of major interest in the context of this syndrome.
Indeed, the activation of ISGs, involved in the immune
response against infections and in tumor surveillance
[55], also inhibits angiogenesis by decreasing the pro-
duction of angiogenic factors such as VEGF and IL8
[56]. Our results clearly show that a similar ISGs activa-
tion occurs in infected DS progenitor cells, and, albeit at
lower levels, in uninfected DS progenitors (data not
shown).
Pathologic immune and inflammatory responses are
regulated by the cross-talk between interferons and TNFa
[26], as well as deregulation of chemokines/cytokines
greatly affects the mobilization and recruitment of
endothelial progenitors. The imbalance between ISGs and
other molecules might be of great immunological relevance
concerning the well-known DS haematological defects.
Conclusions
Physiological angiogenesis plays a central role in the
embryogenesis and placental development; on the other
hand, pathological angiogenesis represents a critical
issue in the progression of many diseases, such as solid
tumor growth and retinopathy.
Individuals with Down syndrome, due to decreased
incidence of angiogenesis-dependent diseases, have been
postulated to be a systemic anti-angiogenesis model.
Indeed, they exhibit a significantly increased anti-angio-
genic surveillance, possibly due to increased expression
of anti-angiogenic regulators on chromosome 21 [57].
However, it has been shown a complex regulation of
gene expression not only related to gene copy number,
with several genes escaping the rule of “increased tran-
scription proportional to the gene copy number”
[58,59]. This findings suggest that many pathological
traits observed in DS may be controlled by other more
complex and, above all tissue-specific, regulatory
mechanisms [59].
Our study shows that circulating endothelial progeni-
tors are reduced in patients with DS, possibly correlating
to the low SDF-1a plasma levels, to a reduced expres-
sion of its membrane receptor in these cells, and to
their higher oxidative stress and pathogen infection sus-
ceptibility compared to euploid cells. A significant per-
turbation in the angiogenesis and inflammation gene
pathways was also observed by microarray analysis,
highlighting that gene expression analysis is a crucial
issue for the study of common diseases. Endothelial dys-
function, angiogenesis’ suppression and infection recur-
rence are hallmarks of DS, and the impairment in the
number and function of circulating progenitors may
account for some of their pathological features. Further
studies are needed to understand possible therapeutic
implications of circulating EPCs in Down syndrome.
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Additional file 1: Supplementary Methods
Additional file 2: Table S1: Primer pairs used for quantitative and
semi-quantitative RT-PCR
Additional file 3: Figure S1: Impaired EPC number and function. A)
Representative photomicrographs of merged double-positive Dil-Ac-LDL/
Lectin cells isolated from euploid (left panel) and DS (right panel)
subjects (100X magnification). B) Fluorescence micrographs of EPCs
labeled for 30 min with C11-BO in euploid and DS subjects. C) EPC
number expressed as percentage in the different phases of cell cycle
obtained by FACS. D) Curves indicate the percentage of EPC number
infected with B. henselae in euploid and DS individuals. Results are
representative of five different experiments in duplicate.
Additional file 4: Table S2: Chromosome 21 genes differentially
expressed in DS vs euploids
Additional file 5: Figure S2: Distribution of differentially expressed
genes along the human chromosomes (DS vs euploids). A) Bar graph
showing the empirical frequency distribution of differentially expressed
genes along the autosomes of DS progenitors vs euploids. Asterisks
indicate the significantly deregulated chromosomes. B) Representation of
the robustness of our findings shown in A. The left column shows the
different user-defined fold-change. For each á value used in the analysis
are shown the relative p-values. C) Bar graph showing the percent of
differentially expressed genes along the DS autosomes.
Additional file 6: Figure S3: Positional gene mapping of
differentially expressed genes (DS vs euploids). Graphic
representation of positional gene enrichment (PGE) approach used to
map differentially expressed genes in DS vs euploids EPCs to the exact
location on the chromosome.
Additional file 7: Figure S4: B. henseale-induced gene expression in
DS EPCs. A) Bar graph showing the top-scored deregulated gene
pathways after infection in DS progenitors. Ratio indicates the percent of
differentially expressed genes within the related pathway. B)
Semiquantitative RT-PCR of Jak/STAT genes deregulated after B. henseale
infection.
Additional file 8: Table S3: Differentially expressed genes after B.
henselae infection
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